9,000 layoffs worldwide
September 11, 2025
Source: drugdu
121
According to ABC News, Danish biopharmaceutical company Novo NordiskOn the 10th, it announced that it would lay off 9,000 employees in a new round of global restructuring, accounting for about 11% of the company's total employees.
As competition in the weight loss drug market intensifies, Novo Nordisk 's move aims to streamline its organizational structure and speed up decision-making. Through the new restructuring plan, Novo Nordisk expects to save 8 billion Danish kroner (about 8.9 billion yuan) in expenses by the end of 2026. The savings will be used for its diabetes and obesity business, including research and development.
Novo Nordisk currently has approximately 78,400 employees worldwide, of which approximately 5,000 are located in Denmark. The company said the layoffs will begin immediately and affected employees will be notified in the coming months in accordance with local labor laws.
Source：https://finance.eastmoney.com/a/202509113510238567.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Multiple batches of quadrivalent influenza virus split vaccine have been sub-packaged and submitted for lot release approval; expected to be released to the market soon after approval December 12, 2025
- Ab&B Bio-Tech CO., LTD. JS Lyophilized Human Rabies Vaccine Initiates Phase III Clinical Trials December 12, 2025
- The ‘Sweetest’ HPV Vaccine Market is Gone | Haibin Interview December 12, 2025
- InnoCare Pharma announced that its first independently developed next-generation TRK inhibitor, zoletrazinib, has been approved for marketing in China December 12, 2025
- Is PD-1/VEGF dual antibody + ADC becoming the standard configuration? December 12, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
